COMPREHENSIVE ASSESSMENT OF THE MARKET DRUGS FOR TREATMENT OF PNEUMONIA IN PEDIATRICS

COMPREHENSIVE ASSESSMENT OF THE MARKET DRUGS FOR TREATMENT OF PNEUMONIA IN PEDIATRICS

The results of present work show that the largest (52%) share of drugs for etiotropic therapy of pneumonia in pediatrics is represented by foreign manufacturers. Asian countries (India (38,45%) and China (6,46%) bring the most contribution into the structure of import. Drugs in form of powders and l...

Full description

Bibliographic Details
Main Authors:	D. D. Siukaeva, O. D. Nemyatyh, I. A. Narkevich, N. I. Pavlenko
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	pharmaceutical market pneumonia pediatrics
Online Access:	https://www.pharmjournal.ru/jour/article/view/531

Similar Items

PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01)

Use of medications in children hospitalized with community-acquired pneumonia
by: D. D. Siukaeva, et al.
Published: (2018-11-01)

Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis
by: I. A. Narkevich, et al.
Published: (2019-01-01)

Risk of Mycoplasma pneumoniae-related hepatitis in MP pneumonia pediatric patients: a predictive model construction and assessment
by: Yuna Bi, et al.
Published: (2021-06-01)

MULTIPLE VIEW MARKETING ANALYSIS OF THE RUSSIAN PLANT-BASED DRUGS MARKET
by: A. V. Akamova, et al.
Published: (2019-01-01)

Causes of ventilator associated pneumonia in pediatrics ICU
by: Alireza Nateghian, et al.
Published: (2016-04-01)

Assessment of consumption of medicines of drugs in conditions of stationary treatment children with acute respiratory viral infections
by: I. A. Narkevich, et al.
Published: (2020-06-01)

The Effect of Interleukin-6 Gene Polymorphism on Pediatric Pneumonia
by: Guode SU, et al.
Published: (2019-11-01)

Determinants of Complicated Pneumonia in Hospitalized Pediatric Patients
by: Mohammadreza Mirkarimi, et al.
Published: (2021-03-01)

COMPREHENSIVE MARKETING STUDY OF THE RUSSIAN PHARMACEUTICAL MARKET DRUGS FOR PREVENTION AND TREATMENT OF DISEASES OF THE THYROID GLAND
by: V. I. Zvereva, et al.
Published: (2019-01-01)

Osteopontin Expression in Cardiomyocytes Is Increased in Pediatric Patients With Sepsis or Pneumonia
by: Camila Iansen Irion, et al.
Published: (2018-12-01)

Epidemiology, microbiology, and treatment patterns of pediatric patients hospitalized with pneumonia at two hospitals in China: a patient chart review study
by: Wen Z, et al.
Published: (2018-03-01)

Risk factors associated with SARS-CoV-2 pneumonia in the pediatric population
by: Moisés Moreno-Noguez, et al.
Published: (2021-10-01)

The first pediatric case of tularemia in Korea: manifested with pneumonia and possible infective endocarditis
by: Jung Sook Yeom, et al.
Published: (2015-10-01)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
by: Merida-Vieyra J, et al.
Published: (2019-04-01)

Pediatric Melanoma and Drug Development
by: Klaus Rose, et al.
Published: (2018-03-01)

The Air Quality and Detection of Streptococcus pneumoniae in the Pediatric Ward of Dr. Hasan Sadikin Hospital Bandung
by: Thiban Raj Manoraj, et al.
Published: (2019-10-01)

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia
by: Lumin Chen, et al.
Published: (2021-04-01)

Pediatric Round Pneumonia
by: Yen-Lin Liu, et al.
Published: (2014-12-01)

Comparison of Clinical Characteristics Among COVID-19 and Non-COVID-19 Pediatric Pneumonias: A Multicenter Cross-Sectional Study
by: Zhongwei Jia, et al.
Published: (2021-07-01)

Risk of Pneumonia in Pediatric Patients Following Minor Chest Trauma: A Population-Based Retrospective Cohort Study
by: Ying-Hsiang Chou, et al.
Published: (2021-04-01)

Management of Community-Acquired Pneumonia in Pediatrics: Adherence to Clinical Guidelines
by: Rim Tannous, et al.
Published: (2020-06-01)

Distribution of capsular types and drug resistance patterns of invasive pediatric Streptococcus pneumoniae isolates in Teheran, Iran
by: Hamidreza Houri, et al.
Published: (2017-04-01)

Typization of Klebsiella pneumoniae strains collected from a immature pediatric ward by Mass Spectrometry using MALDI-TOF
by: Roberto Degl’Innocenti, et al.
Published: (2011-12-01)

Point-of-care ultrasound by the pediatrician in the diagnosis and follow-up of community-acquired pneumonia
by: Manuel Sobrino Toro, et al.
Published: (2021-01-01)

A 5 year (2005-2009) review of antimicrobial susceptibility of clinical Klebsiella pneumoniae isolates from pediatric patients in Jordan
by: Mohammad Al-Shara
Published: (2013-10-01)

MARKETING STUDIES OF LOCAL MARKET OF DRUGS WHICH ARE APPLIED FOR PREVENTION AND TREATMENT OF ORAL CAVITY DISEASES
by: O. A. Tsarakhov, et al.
Published: (2015-11-01)

Investigation and Comparison of Diagnosis and Treatment Guidelines for Community Acquired Pneumonia in terms of Pharmaceutical Care Requirements
by: Melda BAHAP, et al.
Published: (2021-03-01)

Characterization of children younger than 5 Years of age with severe community-acquired alveolar pneumonia (CAAP) requiring Pediatric Intensive Care Unit (PICU) admission
by: Yael Feinstein, et al.
Published: (2020-08-01)

Ambient air pollution is associated with pediatric pneumonia: a time-stratified case–crossover study in an urban area
by: Chi-Yung Cheng, et al.
Published: (2019-08-01)

Pharmacoeconomic Analysis of Drugs Used in the Treatment of Pneumonia in Paediatric Population in a Tertiary Care Hospital in India—A Cost-of-Illness Study
by: Lekha Saha, et al.
Published: (2017-12-01)

Analysis of the domestic pharmaceutical market drugs for the treatment of urolithiasis
by: V. L. Shevina, et al.
Published: (2014-12-01)

Marketing research of the national antiarrhythmic drugs market
by: T. P. Zarichna, et al.
Published: (2019-08-01)

PNEUMONIA IN CHILDREN: IS IT RELATED TO ZINC DEFICIENCY
by: J FAGHIHINIA, et al.
Published: (2001-09-01)

ANALYSIS OF ANTIBIOTICS USE IN PEDIATRIC PNEUMONIA PATIENTS AGED 3 MONTHS - 5 YEARS
by: Dhita Evi Aryani, et al.
Published: (2017-08-01)

Implementation of ventilator bundle for prevention of ventilator-associated pneumonia in pediatric intensive care unit
by: Mohamed F Alsoda, et al.
Published: (2019-01-01)

The epidemiology of hospital death following pediatric severe community acquired pneumonia
by: Xiao-Xiao Ao
Published: (2021-02-01)

Can Serum Surfactant Protein D Levels be used as an Effective Factor Instead of Clinical Severity Scores of Pneumonia in Pediatric Emergency Departments?
by: Mehmet Açıkgöz, et al.
Published: (2016-03-01)

SOME ASPECTS OF THE MARKETING STUDIES FOR THE PHARMACEUTICAL MARKET OF ANTIVIRAL DRUGS
by: A. G. Salnikova, et al.
Published: (2015-12-01)

Evolution of a Round Pneumonia
by: Silver, Matthew, et al.
Published: (2013-11-01)